See the DrugPatentWatch profile for Flavoxate
What is flavoxate, and what patents exist for it?
“Flavoxate” is an older antispasmodic medicine used for urinary bladder spasms (often associated with overactive bladder symptoms). Patent coverage depends on the specific product form (brand vs. generic), country, and whether the question is about the original active-ingredient patents or later patents covering formulations or manufacturing.
Right now, there isn’t enough detail in the question (“Flavoxate paten” is truncated) to identify:
- which patent (active ingredient vs. specific formulation),
- which jurisdiction (US, EU, UK, India, etc.),
- which manufacturer or brand name, or
- what “paten” refers to (patent number, patent expiry, or whether a patent blocks generics).
If you share the country and either a brand/manufacturer name or the patent number (if you have it), I can help pinpoint the relevant patent and its status.
When would a flavoxate patent expire, and can generics enter before that?
Patent expiry timelines depend on the filing and grant dates and on whether there are additional rights (for example, patent “extensions” or secondary patents for formulations). In many older small-molecule drugs, the original ingredient patent is usually well past expiry in major markets, but the key question becomes whether any later patents still cover:
- specific drug salts or polymorphs,
- controlled-release or other special formulations,
- manufacturing processes,
- or trademark/brand exclusivity periods (which are different from patents).
To answer accurately, I’d need the market (e.g., US vs. EU) and the product you care about (immediate-release tablets vs. another dosage form).
Are there patent disputes involving flavoxate or its generics?
Patent disputes (for example, generic challenges to a listed patent) can happen in some markets, but whether they involve flavoxate depends entirely on where the case was filed and which product(s) are at issue. Without a jurisdiction and product identifier, I can’t verify a specific dispute.
What exact detail are you looking for: the patent number, expiry date, or “is it still patented”?
Reply with one of these, and the relevant info you have:
- Country/jurisdiction (US, EU, UK, etc.)
- Brand name (if any) and manufacturer
- Dosage form (tablet, capsule, syrup, etc.)
- Any patent number or link you found
Then I can explain the patent status and what it means for generics in that market.
Sources
None provided—please share the missing details so I can locate the correct flavoxate patent information.